172 related articles for article (PubMed ID: 34923034)
1. Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment.
Christiansen RL; Dysager L; Hansen CR; Jensen HR; Schytte T; Nyborg CJ; Bertelsen AS; Agergaard SN; Mahmood F; Hansen S; Hansen O; Brink C; Bernchou U
Radiother Oncol; 2022 Feb; 167():165-171. PubMed ID: 34923034
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric effects of adaptive prostate cancer radiotherapy in an MR-linac workflow.
Mannerberg A; Persson E; Jonsson J; Gustafsson CJ; Gunnlaugsson A; Olsson LE; Ceberg S
Radiat Oncol; 2020 Jul; 15(1):168. PubMed ID: 32650811
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
Regnery S; Leiner L; Buchele C; Hoegen P; Sandrini E; Held T; Deng M; Eichkorn T; Rippke C; Renkamp CK; König L; Lang K; Adeberg S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2023 May; 18(1):92. PubMed ID: 37248504
[TBL] [Abstract][Full Text] [Related]
6. Image-guided IMRT for localized prostate cancer with daily repositioning: inferring the difference between planned dose and delivered dose distribution.
Arnaud A; Maingon P; Gauthier M; Naudy S; Dumas JL; Martin E; Peignaux-Casasnovas K; Truc G; Bonnetain F; Crehange G
Phys Med; 2014 Sep; 30(6):669-75. PubMed ID: 24792687
[TBL] [Abstract][Full Text] [Related]
7. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles.
Rana S; Cheng C; Zhao L; Park S; Larson G; Vargas C; Dunn M; Zheng Y
J Med Radiat Sci; 2017 Mar; 64(1):18-24. PubMed ID: 27741379
[TBL] [Abstract][Full Text] [Related]
9. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance guided adaptive post prostatectomy radiotherapy: Accumulated dose comparison of different workflows.
Hassan SP; de Leon J; Batumalai V; Moutrie Z; Hogan L; Ge Y; Stricker P; Jameson MG
J Appl Clin Med Phys; 2024 Apr; 25(4):e14253. PubMed ID: 38394627
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Benefit of Magnetic Resonance-guided Adaptive Radiotherapy in Rectal Cancer Patients: a Single-centre Study.
Ingle M; White I; Chick J; Stankiewicz H; Mitchell A; Barnes H; Herbert T; Nill S; Oelfke U; Huddart R; Ng-Cheng-Hin B; Hafeez S; Lalondrelle S; Dunlop A; Bhide S
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e135-e142. PubMed ID: 36336579
[TBL] [Abstract][Full Text] [Related]
12. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
[TBL] [Abstract][Full Text] [Related]
13. Reduction of PTV margins for elective pelvic lymph nodes in online adaptive radiotherapy of prostate cancer patients.
Brennsæter JA; Dahle TJ; Moi JN; Svanberg IF; Haaland GS; Pilskog S
Acta Oncol; 2023 Oct; 62(10):1208-1214. PubMed ID: 37682727
[TBL] [Abstract][Full Text] [Related]
14. Gating has a negligible impact on dose delivered in MRI-guided online adaptive radiotherapy of prostate cancer.
Wahlstedt I; Andratschke N; Behrens CP; Ehrbar S; Gabryś HS; Schüler HG; Guckenberger M; Smith AG; Tanadini-Lang S; Tascón-Vidarte JD; Vogelius IR; van Timmeren JE
Radiother Oncol; 2022 May; 170():205-212. PubMed ID: 35351536
[TBL] [Abstract][Full Text] [Related]
15. Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity.
Ishii K; Ogino R; Hosokawa Y; Fujioka C; Okada W; Nakahara R; Kawamorita R; Tada T; Hayashi Y; Nakajima T
J Radiat Res; 2015 Jan; 56(1):141-50. PubMed ID: 25304328
[TBL] [Abstract][Full Text] [Related]
16. Late toxicity in the randomized multicenter HYPRO trial for prostate cancer analyzed with automated treatment planning.
Sharfo AWM; Dirkx MLP; Bijman RG; Schillemans W; Breedveld S; Aluwini S; Pos F; Incrocci L; Heijmen BJM
Radiother Oncol; 2018 Aug; 128(2):349-356. PubMed ID: 29885745
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy.
Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C
Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
[TBL] [Abstract][Full Text] [Related]
20. Reducing margins for abdominopelvic tumours in dogs: Impact on dose-coverage and normal tissue complication probability.
Meier V; Staudinger C; Radonic S; Besserer J; Schneider U; Walsh L; Rohrer Bley C
Vet Comp Oncol; 2021 Jun; 19(2):266-274. PubMed ID: 33372354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
